These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35320883)

  • 21. National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
    Dottino JA; He W; Sun CC; Zhao H; Fu S; Rauh-Hain JA; Suidan RS; Lu KH; Giordano SH; Meyer LA
    Int J Gynecol Cancer; 2020 Aug; 30(8):1195-1202. PubMed ID: 32616627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified posterior exenteration for ovarian cancer.
    Eisenkop SM; Nalick RH; Teng NN
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):879-85. PubMed ID: 1923216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery.
    Kranawetter M; Ataseven B; Grimm C; Schneider S; Riss S; Alesina P; Prader S; Walz MK; Harpain F; Stift A; Heitz F; Reinthaller A; Polterauer S; Harter P; du Bois A
    Gynecol Oncol; 2019 Sep; 154(3):577-582. PubMed ID: 31235241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
    Williams M; Perera M; Nouhaud FX; Coughlin G
    Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 Patients.
    Paquette B; Kalbacher E; Mercier F; Lakkis Z; Doussot A; Turco C; Caputo E; Pili-Floury S; Royer B; Mansi L; Delroeux D; Demarchi M; Pivot X; Chauffert B; Clement E; Heyd B
    Ann Surg Oncol; 2022 May; 29(5):3322-3334. PubMed ID: 34994906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer.
    Lei Z; Wang Y; Wang J; Wang K; Tian J; Zhao Y; Chen L; Wang J; Luo J; Jia M; Tang H; He Q; Liao Q; Yang X; Guan T; Wang L; Cui S;
    JAMA Netw Open; 2020 Aug; 3(8):e2013940. PubMed ID: 32840622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterior pelvic exenteration, a crucial component in the surgeon's toolbox for optimizing surgical cytoreduction for advanced ovarian cancer.
    Moukarzel LA; Chi DS
    J Gynecol Oncol; 2022 May; 33(3):e41. PubMed ID: 35320890
    [No Abstract]   [Full Text] [Related]  

  • 28. Surgical Complexity Impact on Survival After Complete Cytoreductive Surgery for Advanced Ovarian Cancer.
    Martinez A; Ngo C; Leblanc E; Gouy S; Luyckx M; Darai E; Classe JM; Guyon F; Pomel C; Ferron G; Filleron T; Querleu D
    Ann Surg Oncol; 2016 Aug; 23(8):2515-21. PubMed ID: 27008588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low colorectal anastomosis after radical pelvic surgery: a risk factor analysis.
    Mirhashemi R; Averette HE; Estape R; Angioli R; Mahran R; Mendez L; Cantuaria G; Penalver M
    Am J Obstet Gynecol; 2000 Dec; 183(6):1375-9; discussion 1379-80. PubMed ID: 11120499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.
    Angeles MA; Ferron G; Cabarrou B; Balague G; Martínez-Gómez C; Gladieff L; Pomel C; Martinez A
    Eur J Surg Oncol; 2019 Aug; 45(8):1410-1416. PubMed ID: 30857876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of posterior rectal dissection techniques during rectosigmoid colon resection as part of cytoreductive surgery in patients with epithelial ovarian cancer: Close rectal dissection versus total mesorectal excision.
    Son JH; Kim J; Shim J; Kong TW; Paek J; Chang SJ; Ryu HS
    Gynecol Oncol; 2019 May; 153(2):362-367. PubMed ID: 30846223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncologic outcomes in patients undergoing maximal or optimal cytoreductive surgery for Stage 3C serous ovarian, tubal or peritoneal carcinomas.
    Gurkan D; Ceren Akin A; Sahin H; Aytac Tohma Y; Sahin EA; Gunakan E; Iflazoglu N; Nihan Haberal A; Ayhan A
    J Obstet Gynaecol; 2020 May; 40(4):551-557. PubMed ID: 31482736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pelvic exenteration, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: experience and outcomes from an exenterative and peritonectomy unit.
    Flood MP; Waters PS; Soucisse M; Ramsay R; Michael M; McCormick JJ; Warrier S; Heriot A
    Langenbecks Arch Surg; 2021 Dec; 406(8):2807-2815. PubMed ID: 34495403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.
    Brown J; Drury L; Crane EK; Anderson WE; Tait DL; Higgins RV; Naumann RW
    J Minim Invasive Gynecol; 2019; 26(5):902-909. PubMed ID: 30240899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant Chemotherapy Increases R0 Cytoreduction Rate But Does Not Improve Final Outcome in Advanced Epithelial Ovarian Cancer.
    Medina-Franco H; Cortés-González R; Lambreton-Hinojosa F; Fimbres-Morales A; Vargas-Siordia JC
    Ann Surg Oncol; 2017 May; 24(5):1330-1335. PubMed ID: 27995454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified posterior pelvic exenteration for ovarian cancer.
    Houvenaeghel G; Gutowski M; Buttarelli M; Cuisenier J; Narducci F; Dalle C; Ferron G; Morice P; Meeus P; Stockle E; Bannier M; Lambaudie E; Rouanet P; Fraisse J; Leblanc E; Dauplat J; Querleu D; Martel P; Castaigne D
    Int J Gynecol Cancer; 2009 Jul; 19(5):968-73. PubMed ID: 19574794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total retroperitoneal en bloc resection of multivisceral-peritoneal packet (TROMP operation): a novel surgical technique for advanced ovarian cancer.
    Muallem MZ; Sehouli J; Miranda A; Richter R; Muallem J
    Int J Gynecol Cancer; 2020 May; 30(5):648-653. PubMed ID: 32221020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.